CCDC173 Inhibitors
CCDC173 inhibitors, as a class, include chemicals that interfere with the protein's function by indirectly affecting the cellular processes or signaling pathways in which CCDC173 participates. Although not directly targeting CCDC173, the listed compounds are involved in the regulation of kinase activity or kinase-mediated signaling pathways, which are essential for various cellular functions. Inhibition of these pathways can lead to a change in the phosphorylation state of numerous proteins, potentially including CCDC173, thereby affecting its function.
These inhibitors can act at different levels in cellular signaling processes. For example, staurosporine is known to be a broad-spectrum kinase inhibitor that can affect a wide variety of kinases by competing with ATP for binding to the active site of these enzymes. Wortmannin and LY294002 specifically inhibit PI3K, which is a key component of one of the primary signaling pathways that regulate cell survival and metabolism. This alteration in PI3K activity can cascade down to affect various proteins and processes in the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent kinase inhibitor that can prevent phosphorylation, a modification that may alter CCDC173 activity or interaction with other proteins. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, a kinase involved in many signaling pathways; altered PI3K activity can influence CCDC173 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor that disrupts downstream signaling that may indirectly affect CCDC173 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR kinase which is involved in cell growth and proliferation, potentially influencing CCDC173 through complex signaling networks. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Inhibits Src family kinases and other kinases, possibly affecting signaling pathways that interact with CCDC173. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $85.00 $132.00 $287.00 $495.00 $3752.00 | 42 | |
Inhibits EGFR tyrosine kinase, thereby affecting kinase signaling pathways that may involve CCDC173. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Inhibits multiple receptor tyrosine kinases and may affect signaling pathways connected to CCDC173 activity. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
Inhibits receptor tyrosine kinases which could impact signaling pathways involving CCDC173. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Targets BCR-ABL and other tyrosine kinases, potentially influencing signaling pathways involving CCDC173. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2 in the MAPK/ERK pathway, which may indirectly affect CCDC173 activity. | ||||||